Muts Homolog 2 (msh2) - Cancer Science

Relevant Publications

Clinicopathological Implications of Mismatch Repair Status in Endometrioid Endometrial Cancer in Duhok City.

Issue Release: 2024

Enterohemorrhagic effector EspF triggers oxidative DNA lesions in intestinal epithelial cells.

Issue Release: 2024

Circ_0025373 inhibits carbon black nanoparticles-induced malignant transformation of human bronchial epithelial cells by affecting DNA damage through binding to MSH2.

Issue Release: 2024

Association of glutaminase expression with immune-suppressive tumor microenvironment, clinicopathologic features, and clinical outcomes in endometrial cancer.

Issue Release: 2024

Next-generation sequencing uncovers crucial mutated genes and potential therapeutic targets in ovarian cancer patients.

Issue Release: 2024

[Association Between the Protein Expressions of MutS Homologs and Villin and the Clinicopathological Characteristics in 310 Colon Cancer Patients].

Issue Release: 2024

Ataxia Telangiectasia Mutated and MSH2 Control Blunt DNA End Joining in Ig Class Switch Recombination.

Issue Release: 2023

Germline Testing of Mismatch Repair Genes Is Needed in the Initial Evaluation of Patients With Muir-Torre Syndrome-Associated Cutaneous Sebaceous Neoplasms: A Case Series.

Issue Release: 2023

A novel germline frameshift mutation in the MLH1 gene in a patient with Lynch syndrome.

Issue Release: 2023

Metabolomic profiling for the preventive effects of dietary grape pomace against colorectal cancer.

Issue Release: 2023

Correlations between MSH2 and MSH6 Concentrations in Different Biological Fluids and Clinicopathological Features in Colorectal Adenocarcinoma Patients and Their Contribution to Fast and Early Diagnosis of Colorectal Adenocarcinoma.

Issue Release: 2023

Early-Onset/Young-Onset Colorectal Carcinoma: A Comparative Analysis of Morphological Features and Biomarker Profile.

Issue Release: 2023

Immunoexpression of Mismatch Repair Proteins in a Cohort of Colorectal Cancer Patients.

Issue Release: 2023

Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comparison Between Mismatch Repair Protein Immunostaining and Microsatellite Instability Testing.

Issue Release: 2023

Mismatch Repair Deficient (dMMR) Colorectal Carcinoma in a Pakistani Cohort: Association With Clinical and Pathological Parameters.

Issue Release: 2023

A Pan-Cancer Analysis on the Systematic Correlation of MutS Homolog 2 (MSH2) to a Malignant Tumor.

Issue Release: 2022

High MutS homolog 2 expression predicts poor prognosis and is related to immune infiltration in endometrial carcinoma.

Issue Release: 2022

A tumor association to be aware: endometrial cancer and colon cancer in relation to Lynch syndrome.

Issue Release: 2022

MEX3A impairs DNA mismatch repair signaling and mediates acquired temozolomide resistance in glioblastoma.

Issue Release: 2022

Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma.

Issue Release: 2022

Why is Cancer Fraud Prevalent?

When should hearing tests be conducted for cancer patients?

Can Cancer Treatments Cause Myocardial Ischemia?

What Are the Advances in Radiation Therapy?

What Is the Future of Anti-Cancer Drugs?

What Are Some Notable Contributions from JCO?

What Are the Benefits of Using Wearable Technology for Cancer Patients?

How Does GATK Work?

How Do Residual Cancer Cells Survive Treatment?

What is the Prognosis for Patients with Bone Lesions?

Muts Homolog 2 (msh2) - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics